Table 1.
Non-OXY group x(N = 35) | OXY group (N = 29) | |
---|---|---|
Mean age (range) | 64.9 (48–76) | 62.7 (48–75) |
Gender | ||
Male | 19 | 16 |
Female | 17 | 13 |
Stage | ||
IIIA | 1 | 0 |
IIIB | 4 | 2 |
IIIC | 7 | 2 |
IV | 23 | 25 |
Chemotherapy regimen | ||
mFOLFOX | 28 | 9 |
mFOLFOX + bevacizumab | 7 | 18 |
mFOLFOX + bevacizumab + panitumumab | 0 | 2 |